Advancing the Science of Immuno-Oncology
At Aptevo, we are advancing a new generation of targeted immunotherapies designed to harness the power of the immune system with precision. Our work is grounded in deep expertise in multispecific antibody engineering, with a focus on developing therapies for patients facing difficult-to-treat cancers and areas of significant unmet medical need.
Our therapeutic candidates are purpose-built with both innovation and clinical practicality in mind — designed to engage multiple immune pathways while supporting potential combinability with existing standards of care and emerging treatment technologies. Through this approach, Aptevo is working to expand what may be possible for patients with cancer.
